Fundraising Fox
/Companies
Sign in

Enterprise Therapeutics

Brighton, GB · 6 known investors

Find your way into Enterprise Therapeutics

Sign up to see every warm intro you have to Enterprise Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Enterprise Therapeutics team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Enterprise Therapeutics is a drug discovery company developing therapies for respiratory diseases such as cystic fibrosis, asthma, and COPD. Its research targets the underlying mechanisms of mucus congestion in the lungs to reduce lung infections and improve patient quality of life.

BiotechHealthtech

Founders & leadership

JFJohn Ford
John FordCo-founderCo-founder of Enterprise Therapeutics, a drug discovery company focused on respiratory disease treatments. Ford has previously built and exited multiple biotechnology companies.
MGMartin Gosling
Martin GoslingFounderMartin Gosling is a scientist with experience in disease biology, target identification, and drug discovery across academic, biotech, and industry roles. He has led work on multiple therapeutic areas and ion channel platforms.

Investors · 6

Novartis Venture Fundlisted by Novartis Venture FundBasel · $5M – $25M

How we know: Novartis Venture Fund's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Versant Ventureslisted by Versant VenturesSan Francisco · $250K – $5M

How we know: Versant Ventures's portfolio page · Not right? Tell us

ForbionreportedNaarden

How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us

IP GroupreportedLondon

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Panakes PartnersreportedMilan

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Related companies · 3

AlumniAstraZeneca develops and markets pharmaceutical products, vaccines, and biologics across oncology, cardiovascular disease, respiratory and immunology, and rare disease areas, serving patients and healthcare providers globally.
Atea PharmaceuticalsAtea is a clinical-stage biopharmaceutical company developing oral direct-acting antiviral therapies for single-stranded RNA viruses, currently focused on a bemnifosbuvir and ruzasvir regimen in Phase 3 development for hepatitis C virus (HCV). Its work spans antiviral drug discovery, medicinal chemistry, biology, and virology.
DoximityDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.

Companies working in the same space as Enterprise Therapeutics.

Frequently asked questions

What does Enterprise Therapeutics do?
Enterprise Therapeutics is a drug discovery company developing therapies for respiratory diseases such as cystic fibrosis, asthma, and COPD. Its research targets the underlying mechanisms of mucus congestion in the lungs to reduce lung infections and improve patient quality of life.
Who founded Enterprise Therapeutics?
Enterprise Therapeutics was founded by John Ford.
Who are Enterprise Therapeutics's investors?
Enterprise Therapeutics's investors include Epidarex Capital, Novartis Venture Fund, Versant Ventures, Forbion, IP Group, Panakes Partners.
Where is Enterprise Therapeutics headquartered?
Enterprise Therapeutics is headquartered in Brighton, GB.